Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28726 - 28750 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cytarabine	Approved Investigational	ST6GALNAC3	256435	downregulated	Cytarabine results in decreased expression of ST6GALNAC3 mRNA	1p31.1	A21886
Cytarabine	Approved Investigational	ST6GALNAC6	30815	downregulated	Cytarabine results in decreased expression of ST6GALNAC6 mRNA	9q34.11	A21886
Cytarabine	Approved Investigational	STOM	2040	downregulated	Cytarabine results in decreased expression of STOM mRNA	9q33.2	A21886
Cytarabine	Approved Investigational	STON1	11037	downregulated	Cytarabine results in decreased expression of STON1 mRNA	2p16.3	A21886
Cytarabine	Approved Investigational	SURF4	6836	downregulated	Cytarabine results in decreased expression of SURF4 mRNA	9q34.2	A21886
Cytarabine	Approved Investigational	SVEP1	79987	downregulated	Cytarabine results in decreased expression of SVEP1 mRNA	9q31.3	A21886
Cytarabine	Approved Investigational	SYTL2	54843	upregulated	Cytarabine results in increased expression of SYTL2 mRNA	11q14.1	A21886
Cytarabine	Approved Investigational	TAC1	6863	upregulated	Cytarabine results in increased expression of TAC1 mRNA	7q21.3	A21886
Cytarabine	Approved Investigational	TAC3	6866	downregulated	Cytarabine results in decreased expression of TAC3 mRNA	12q13.3	A21886
Cytarabine	Approved Investigational	TAGLN	6876	upregulated	Cytarabine results in increased expression of TAGLN mRNA	11q23.2	A21886
Cytarabine	Approved Investigational	TBC1D4	9882	downregulated	Cytarabine results in decreased expression of TBC1D4 mRNA	13q22.2	A21886
Cytarabine	Approved Investigational	TCEAL7	56849	upregulated	Cytarabine results in increased expression of TCEAL7 mRNA	Xq22.2	A21886
Cytarabine	Approved Investigational	TCF12	6938	upregulated	Cytarabine results in increased expression of TCF12 mRNA	15q21.3	A21886
Cytarabine	Approved Investigational	TCF21	6943	downregulated	Cytarabine results in decreased expression of TCF21 mRNA	6q23.2	A21886
Cytarabine	Approved Investigational	TCF25	22980	downregulated	Cytarabine results in decreased expression of TCF25 mRNA	16q24.3	A21886
Cytarabine	Approved Investigational	TECRL	253017	downregulated	Cytarabine results in decreased expression of TECRL mRNA	4q13.1	A21886
Cytarabine	Approved Investigational	TEK	7010	downregulated	Cytarabine results in decreased expression of TEK mRNA	9p21.2	A21886
Cytarabine	Approved Investigational	TFE3	7030	upregulated	Cytarabine results in increased expression of TFE3 mRNA	Xp11.23	A20985
Cytarabine	Approved Investigational	TFF3	7033	upregulated	Cytarabine results in increased expression of TFF3 mRNA	21q22.3	A21886
Cytarabine	Approved Investigational	TFPI	7035	downregulated	Cytarabine results in decreased expression of TFPI mRNA	2q32.1	A21886
Cytarabine	Approved Investigational	TGFBR3	7049	downregulated	Cytarabine results in decreased expression of TGFBR3 mRNA	1p22.1	A21886
Cytarabine	Approved Investigational	THBS1	7057	upregulated	Cytarabine results in increased expression of THBS1 mRNA	15q14	A21886
Cytarabine	Approved Investigational	THY1	7070	downregulated	Cytarabine results in decreased expression of THY1 mRNA	11q23.3	A20985
Cytarabine	Approved Investigational	TIMP1	7076	downregulated	Cytarabine results in decreased expression of TIMP1 mRNA	Xp11.3	A21886
Cytarabine	Approved Investigational	TK1	7083	downregulated	Cytarabine results in decreased expression of TK1 mRNA	17q25.3	A21888

Displaying entries 28726 - 28750 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability